C[C@H]1CN([C@H](C)CO)C(=O)c2cccc(NC(=O)CCC(F)(F)F)c2O[C@@H]1CN(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?